TABLE 2.
Distribution of IL-17 and IL-23 levels according to demographic findings in CLL
| Group | Variables | IL-17 (ng/L) | p | IL-23 (ng/L) | p |
|---|---|---|---|---|---|
| CLL | |||||
| Gender | Female | 51.0 (11.2–413.5) | 0.238 | 64.1 (12.0–428.2) | 0.029* |
| Male | 16.9 (11.0–97.5) | 12.7 (6.0–108.8) | |||
| Age | r=0.117 | 0.605 | r=0.230 | 0.304 | |
| Control | |||||
| Gender | |||||
| Female | 14.6 (11.2–46.1) | 0.468 | 13.1 (6.0–55.1) | 0.282 | |
| Male | 22.0 (11.1–213.7) | 21.9 (9.9–533.8) | |||
| Age | r=0.001 | 0.999 | r=0.095 | 0.683 |
Numerical variables were shown as median (min–max) according to normality distribution. r: Spearman correlation coefficient;
p<0.05 shows statistical significance; CLL: Chronic lymphocytic leukemia; DC: Direct coombs; IL-17: Interleukin -17; IL-23: Interleukin-23.